Women often report nausea, fatigue, constipation, and changes in menstrual cycles
What Is Retatrutide (GLP-3)
While the costs of the two medications are similar, there is research that highlights semaglutide GLP-1 as the more cost-effective option when it comes to weight loss treatment
Retatrutide is an investigational triple agonist acting on GLP-1, GIP, and glucagon receptors, but it has not received MHRA marketing authorisation and cannot be legally prescribed in the UK
These medications initially may cause nausea, vomiting, or diarrhea, especially early on
The study randomized 2,339 adults with obesity or overweight to receive retatrutide 4 mg, 9 mg, 12 mg, or placebo